Alternatives to Regenxbio
Regenxbio is a Biotech tool: clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases. Here are the 46 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Regenxbio
Travere TherapeuticsNot ratedA biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
Lexeo TherapeuticsNot ratedClinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Tenaya TherapeuticsNot ratedBiotechnology company developing gene therapies and regenerative medicine for heart disease.
BioLife SolutionsNot ratedDevelops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.
Avidity BiosciencesNot ratedClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Bluebird BioNot ratedGene therapy company developing transformative treatments for severe genetic diseases.
Orchard TherapeuticsNot ratedGene therapy company developing treatments for rare inherited diseases.
Intellia TherapeuticsNot ratedA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Gene Bio MedicalNot ratedDevelops advanced gene editing and cell therapy solutions for rare genetic diseases.
Adaptive BiotechnologiesNot ratedLeveraging the adaptive immune system to diagnose and treat disease.
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
SynthaceNot ratedSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
Cue Biopharma, .Not ratedDeveloping engineered biologics to harness the immune system for disease treatment.
Caris Life SciencesNot ratedCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Amicus TherapeuticsNot ratedBiotechnology company focused on developing treatments for rare metabolic diseases.
Guardant HealthNot ratedGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
Harmony Biosciences HoldingsNot ratedBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
Mustang BioNot ratedClinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.
UltragenyxNot ratedBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
CellcolabsNot ratedAI-powered platform for personalized cell therapy development and manufacturing.
Showing the next 20 closest matches. See the rest on the Regenxbio profile.
Sponsored rows are paid and labelled. Advertise on this page

